GT Biopharma Selected for Oral Presentation at SITC Annual Meeting

PUBT · 1d ago
GT Biopharma Selected for Oral Presentation at SITC Annual Meeting
  • GT Biopharma will give an oral presentation at the SITC 2026 Annual Meeting, scheduled for Nov. 4-8 in Phoenix.
  • The presentation on KRAS inhibition sensitizing pancreatic cancer to NK cell immunotherapy is scheduled for Nov. 6, 3:05-3:20 p.m. MT.
  • Paarth Dodhiawala of the University of Minnesota Medical School will present.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GT Biopharma Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610260800PRIMZONEFULLFEED9852381) on October 26, 2026, and is solely responsible for the information contained therein.